E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 11
7 / 11Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Review Article
Online Published: 21 Aug 2022
 


Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries

Yuni Astria, Hartono Gunardi.


Abstract
Background. Pneumonia is one of the most common causes of morbidity and mortality in children below 5 years of age. Most cases occur in low-middle income countries. The introduction of Pneumococcus Conjugate Vaccines (PCV) became an alternative way to prevent pneumonia, but limited fundings restrict implementation of PCV in national immunization program especially in developing countries. It is important to explore the effectivity and efficiency PCV10 compared to PCV13 to prevent pneumonia.
Aim. To identify the immunogenicity and efficacy of PCV10 compared to PCV13 among infants in developing countries.
Method. Electronic online literature searching was conducted through Pubmed and Cochrane with keywords “PCV10”, OR “PCV13”, AND “pneumonia”, AND “immunogenicity”, AND “infants”.
Results. Two relevant articles were available and then were appraised. A study by Pomat et al with 1b level of evidence found the incidence of pneumonia for after PCV10 and PCV13 immunization were 25% and 19%, respectively. Protective IgG concentration for all serotypes (≥0,35 mcq/mL) after the administration of three primary doses (3+0) for either PCV10 or PCV13 was found to be available in 77% subjects at 4 months old. Temple et al (1b level of evidence) showed the proportion of subjects with protective IgG concentration for all serotypes in both PCV10 and PCV13 groups is 76.8-100%.
Conclusion. Either PCV10 or PCV13 has almost similar effectivity and efficacy for immunogenicity and preventing the incidence of pneumonia. Other considerations in vaccine selections are local pneumococcal serotypes, price, and availability of vaccines for the long run.

Key words: PCV-10, PCV-13, immunogenicity, pneumonia, infants, developing, countries


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Yuni Astria
Articles by Hartono Gunardi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Astria Y, Gunardi H, . Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. Int J Med Rev Case Rep. 2022; 6(9): 40-46. doi:10.5455/IJMRCR.172-1615350531

Web Style

Astria Y, Gunardi H, . Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. https://www.mdpub.net/?mno=62675 [Access: October 14, 2024]. doi:10.5455/IJMRCR.172-1615350531

AMA (American Medical Association) Style

Astria Y, Gunardi H, . Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. Int J Med Rev Case Rep. 2022; 6(9): 40-46. doi:10.5455/IJMRCR.172-1615350531


Vancouver/ICMJE Style

Astria Y, Gunardi H, . Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. Int J Med Rev Case Rep. (2022), [cited October 14, 2024]; 6(9): 40-46. doi:10.5455/IJMRCR.172-1615350531


Harvard Style

Astria, Y., Gunardi, H. & (2022) Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. Int J Med Rev Case Rep, 6 (9), 40-46. doi:10.5455/IJMRCR.172-1615350531


Turabian Style

Astria, Yuni, Hartono Gunardi, and . 2022. Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. International Journal of Medical Reviews and Case Reports, 6 (9), 40-46. doi:10.5455/IJMRCR.172-1615350531


Chicago Style

Astria, Yuni, Hartono Gunardi, and . "Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries." International Journal of Medical Reviews and Case Reports 6 (2022), 40-46. doi:10.5455/IJMRCR.172-1615350531


MLA (The Modern Language Association) Style

Astria, Yuni, Hartono Gunardi, and . "Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries." International Journal of Medical Reviews and Case Reports 6.9 (2022), 40-46. Print. doi:10.5455/IJMRCR.172-1615350531


APA (American Psychological Association) Style

Astria, Y., Gunardi, H. & (2022) Incidence of Pneumonia and Immunogenicity of 10-Valent Compared to 13-Valent Pneumococcal Conjugate Vaccines among Infants in Developing Countries. International Journal of Medical Reviews and Case Reports, 6 (9), 40-46. doi:10.5455/IJMRCR.172-1615350531


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500